The mTOR inhibitor everolimus suppressed tumor growth in the mouse model of colon cancer-induced peritoneal carcinomatosis when administered orally or in combination with capecitabine. However, the limitation of this study was the small sample size. Our study is unique because it has investigated whether peritoneal carcinomatosis could be treated with oral chemotherapeutic agents.
http://www.revistamedicinamilitara.ro/wp-content/uploads/2021/11/1.RJMM-vol-CXXIV-nr-4-din-2021.pdf
Romanian Journal of Military Medicine
http://www.revistamedicinamilitara.ro/
http://www.revistamedicinamilitara.ro/wp-content/uploads/2021/11/1.RJMM-vol-CXXIV-nr-4-din-2021.pdf
No comments:
Post a Comment